Metabolic Syndrome Clusters and Arterial Stiffness: Unraveling Early Predictors of Cardiovascular Risk in a Follow-Up

Agnė Jucevičienė1,2, Ligita Ryliškytė1, Jolita Badarienė1,2

  • 1Clinic of Cardiovascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio Str. 21, LT-03101 Vilnius, Lithuania.

Insights

Metabolic syndrome (MetS) component clusters and arterial stiffness increase cardiovascular event risk. Specific combinations like WTBG and WTHBG are linked to stiffer arteries and higher event rates.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Vascular Health

Background:

  • Metabolic syndrome (MetS) is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes.
  • Arterial stiffness is a key indicator of cardiovascular health and a predictor of future cardiovascular events.

Purpose of the Study:

  • To assess the association between different metabolic syndrome (MetS) component clusters, arterial stiffness (aortic pulse wave velocity [aPWV] and cardio-ankle vascular index [CAVI]), and major cardiovascular events.
  • To identify specific MetS component combinations that predict increased cardiovascular risk and arterial stiffness.

Main Methods:

  • Prospective cohort study of 5307 participants (aged 40-64) with MetS, free of cardiovascular disease.
  • Average follow-up of 4.57 years to monitor major cardiovascular events.
  • Arterial stiffness measured by aPWV and CAVI; statistical analysis of MetS clusters, arterial stiffness, and cardiovascular outcomes.

Main Results:

  • 3.34% of subjects experienced a major cardiovascular event.
  • Individuals with four MetS criteria had higher event risk than those with three.
  • Elevated triglycerides and glucose were significantly associated with increased risk.
  • Specific MetS clusters (WBG, WTHB) and combinations (WBG, WTBG, WTHBG) were significantly associated with cardiovascular events and higher arterial stiffness (aPWV, CAVI).
  • Clusters WTBG and WTHBG were linked to more than double the odds of extremely stiff arteries (aPWV > 95th percentile).

Conclusions:

  • Increased arterial stiffness and a higher number of MetS components are associated with a higher risk of cardiovascular events.
  • Specific MetS components, particularly elevated triglycerides and glucose, contribute significantly to this risk.
  • Unfavorable MetS component combinations (WTBG, WTHBG, WTB) are strongly associated with extremely stiff arteries, indicating a heightened risk profile.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
882
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
470
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
923
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
800
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
540